52 results
Page 2 of 3
8-K
EX-99.1
d11f0hsm
21 Jul 21
Other Events
5:17pm
425
EX-99.1
ywugicwkyq 1nz5o
21 Jul 21
Business combination disclosure
5:15pm
424B3
v2n6g vmraspwrf1o
15 Jul 21
Prospectus supplement
4:45pm
S-4/A
ucflftcat1bdxj0
13 Jul 21
Registration of securities issued in business combination transactions (amended)
4:41pm
S-4
cmr carx5
1 Jul 21
Registration of securities issued in business combination transactions
12:00am
DEF 14A
0z90aaaun61aal22i5t
9 Sep 20
Definitive proxy
4:00pm
8-K
EX-99.1
u2gez1zk7
31 Aug 20
Acasti Pharma Reports Topline Triglyceride Results from Phase 3 TRILOGY 2 Study of CaPre in Patients with Severe Hypertriglyceridemia
4:05pm
PRE 14A
p9u0 eccd
10 Aug 20
Preliminary proxy
12:00am
10-K
uxryhchx3ky
29 Jun 20
Annual report
4:02pm
8-K
EX-99.1
bpqmv8fnfba92r47k8
29 Jun 20
Acasti Pharma Provides Fiscal 2020 Year-End Business Update
12:50pm
8-K
29rpjvier ma
19 Jun 20
Acasti Pharma Receives FDA Response to TRILOGY 1 Briefing Package
9:09am
8-K
EX-99.1
0zuc4965qx7ije8
19 Jun 20
Acasti Pharma Receives FDA Response to TRILOGY 1 Briefing Package
9:09am
6-K
EX-99.1
rx91bhrxy jm
6 Aug 19
Notice of Annual and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
ns0xae
26 Mar 19
Acasti Pharma to Present at the 2019 Spring Investor Summit in New York City on April 2nd
8:30am
6-K
EX-99.1
b71sv
9 Oct 18
Current report (foreign)
5:21pm